Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Breast Neoplasms and TOP2A[original query] |
---|
Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization. Archives of pathology & laboratory medicine 2005 1 129 (1): 39-46. Murthy Sabita K, Magliocco Anthony M, Demetrick Douglas |
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Aug 27 (24): 3881-6. Tubbs Raymond, Barlow William E, Budd G Thomas, Swain Eric, Porter Peggy, Gown Allen, Yeh I-Ten, Sledge George, Shapiro Charles, Ingle James, Haskell Charles, Albain Kathy S, Livingston Robert, Hayes Daniel |
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. Journal of the National Cancer Institute 2009 May 101 (9): 644-50. O'Malley F P, Chia S, Tu D, Shepherd L E, Levine M N, Bramwell V H, Andrulis I L, Pritchard K |
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer. Breast cancer research and treatment 2010 Apr 120 (2): 481-9. Konecny Gottfried E, Pauletti Giovanni, Untch Michael, Wang He-Jing, Möbus Volker, Kuhn Walther, Thomssen Christoph, Harbeck Nadia, Wang Ling, Apple Sophia, Jänicke Fritz, Slamon Dennis |
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab. Journal of translational medicine 2012 10 (1): 212. Fountzilas George, Christodoulou Christos, Bobos Mattheos, Kotoula Vassiliki, Eleftheraki Anastasia G, Xanthakis Ioannis, Batistatou Anna, Pentheroudakis George, Xiros Nikolaos, Papaspirou Irene, Koumarianou Anna, Papakostas Pavlos, Bafaloukos Dimitrios, Skarlos Dimosthenis V, Kalogeras Konstantine |
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials. BMC cancer 2013 13 (1): 163. Fountzilas George, Dafni Urania, Bobos Mattheos, Kotoula Vassiliki, Batistatou Anna, Xanthakis Ioannis, Papadimitriou Christos, Kostopoulos Ioannis, Koletsa Triantafillia, Tsolaki Eleftheria, Televantou Despina, Timotheadou Eleni, Koutras Angelos, Klouvas George, Samantas Epaminontas, Pisanidis Nikolaos, Karanikiotis Charisios, Sfakianaki Ioanna, Pavlidis Nicholas, Gogas Helen, Linardou Helena, Kalogeras Konstantine T, Pectasides Dimitrios, Dimopoulos Meletios |
HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics. Breast cancer research and treatment 2014 May 145 (1): 193-203. Fasching Peter A, Weihbrecht Sebastian, Haeberle Lothar, Gasparyan Armen, Villalobos Ivonne E, Ma Yanling, Ekici Arif B, Wachter David L, Hartmann Arndt, Beckmann Matthias W, Slamon Dennis J, Press Michael |
Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cellular oncology (Dordrecht) 2014 Apr 37 (2): 107-18. Tabarestani Sanaz, Ghaderian Sayyed Mohammad Hossein, Rezvani Hamid, Mirfakhraie Reza, Ebrahimi Abdolali, Attarian Hamid, Rafat Jahangir, Ghadyani Mojtaba, Alavi Hossein Afshin, Kamalian Naser, Rakhsha Afshin, Azargashb Eznoll |
TOP2A gene copy number change in breast cancer. Journal of clinical pathology 2014 May 67 (5): 420-5. Engstrøm M J, Ytterhus B, Vatten L J, Opdahl S, Bofin A |
Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer. Oncology reports 2017 May 37 (5): 3026-3036. Dimas-González Jisela, Maldonado-Lagunas Vilma, Díaz-Chávez José, López-Arellano María Eugenia, Muñoz-Camacho José, Terán-Porcayo Marco Antonio, Lagunas-Martínez Alfre |
Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer. Oncology letters 2019 Jun 17 (6): 5469-5480. Zhu Lizhe, Ma Nan, Wang Bin, Zhou Can, Yan Yu, Wang Ke, He Jianjun, Ren |
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 4 25 (13): 3986-3995. Loibl Sibylle, Treue Denise, Budczies Jan, Weber Karsten, Stenzinger Albrecht, Schmitt Wolfgang D, Weichert Wilko, Jank Paul, Furlanetto Jenny, Klauschen Frederick, Karn Thomas, Pfarr Nicole, von Minckwitz Gunter, Möbs Markus, Jackisch Christian, Sers Christine, Schneeweiss Andreas, Fasching Peter A, Schem Christian, Hummel Michael, van Mackelenbergh Marion, Nekljudova Valentina, Untch Michael, Denkert Carst |
[Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy]. Anales del sistema sanitario de Navarra 2023 8 46 (2): . Patricia Iranzo, Ana Callejo, Julio Arbej, Sebastian Menao, Dolores Isla, Raquel Andr |
Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. Journal of Cancer 2024 7 15 (14): 4467-4476. Gang Ma, Binliang Huo, Yanwei Shen, Xulong Zhu, Chong Cheng, Wensheng Li, Wei Cao, Jianhui |
- Page last reviewed:Feb 1, 2024
- Content source: